Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycled Testosterone During Pulmonary Rehabilitation in COPD
NCT03674320Phase 3Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Dec 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone enanthate in chronic obstructive pulmonary disease (COPD), sponsored by The University of Texas Medical Branch at Galveston. Planned start Dec 2021; status: withdrawn.
02
Drugs
testosterone enanthate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03674320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03674320.